The NASDAQ website lists adds and subtracts from institutional holders in Q1, 2013, as well as other previous quarters. Royce and a few other holder disposed of some shares. It's all part of the ebb and flow, since TRIB has almost 50% of it's stock in institutional hands. Yes there was a big swoon up to 19, but obviously some big firepower took it up there,and does strongly believe it's not only going back, but higher.
So I guess the "it's worth 21 now" and 24 in the future is going to be on hold for a bit, eh? The good news is that we get our dividend rate back to 1.0%,with he .15/ADR now at a stock price of 15 or so dollars. :)
It is now below the $15.5 price target given by Roth Capital in their downgrade to neutral last January. The stock price went up based on hype and momentum, not because of actual performance by the company. Growth has been in the single digit and the company had profits because it had spent very little on R&D. If there are no favorable news on approval in China and Brazil (that are long overdue) , the share price will go nowhere unless Ronan hypes successfully the progress of Fiomi. Anyone being in this stock for many years should regard Ronan's claims with great suspicion. Personally, I've lightened up on my holding leaving only 2K shares riding on the hope for Fiomi's cardiac instruments.